These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26918391)

  • 1. N-ω-chloroacetyl-L-ornithine has in-vitro activity against cancer cell lines and in-vivo activity against ascitic and solid tumors.
    Vargas-Ramírez AL; Medina-Enríquez MM; Cordero-Rodríguez NI; Ruiz-Cuello T; Aguilar-Faisal L; Trujillo-Ferrara JG; Alcántara-Farfán V; Rodríguez-Páez L
    Anticancer Drugs; 2016 Jul; 27(6):508-18. PubMed ID: 26918391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-ω-chloroacetyl-l-ornithine, a new competitive inhibitor of ornithine decarboxylase, induces selective growth inhibition and cytotoxicity on human cancer cells versus normal cells.
    Medina-Enríquez MM; Alcántara-Farfán V; Aguilar-Faisal L; Trujillo-Ferrara JG; Rodríguez-Páez L; Vargas-Ramírez AL
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):345-53. PubMed ID: 24939101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chikungunya virus replication by N-ω-Chloroacetyl-L-Ornithine in C6/36, Vero cells and human fibroblast BJ.
    Rojas-Luna L; Posadas-Modragón A; Avila-Trejo AM; Alcántara-Farfán V; Rodríguez-Páez LI; Santiago-Cruz JA; Pastor-Alonso MO; Aguilar-Faisal JL
    Antivir Ther; 2023 Feb; 28(1):13596535231155263. PubMed ID: 36724136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
    Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
    Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
    Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
    J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of edotecarin in breast carcinoma models.
    Ciomei M; Croci V; Stellari F; Amboldi N; Giavarini R; Pesenti E
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):229-35. PubMed ID: 17089166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological evaluation of a new family of aminosteroids that display a selective toxicity for various malignant cell lines.
    Jegham H; Maltais R; Roy J; Doillon C; Poirier D
    Anticancer Drugs; 2012 Sep; 23(8):803-14. PubMed ID: 22361842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diorganotin(IV) derivatives of substituted N-hydroxybenzamides with selective cytotoxicity in vitro and potent antitumor activity in vivo.
    Li YL; Wang ZW; Guo P; Tang L; Ge R; Ban SR; Chai QY; Niu L; Li QS
    J Inorg Biochem; 2014 Apr; 133():1-7. PubMed ID: 24413257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
    LaCasse EC; Cherton-Horvat GG; Hewitt KE; Jerome LJ; Morris SJ; Kandimalla ER; Yu D; Wang H; Wang W; Zhang R; Agrawal S; Gillard JW; Durkin JP
    Clin Cancer Res; 2006 Sep; 12(17):5231-41. PubMed ID: 16951243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
    Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
    Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
    Duan YT; Man RJ; Tang DJ; Yao YF; Tao XX; Yu C; Liang XY; Makawana JA; Zou MJ; Wang ZC; Zhu HL
    Sci Rep; 2016 May; 6():25387. PubMed ID: 27138035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.
    Nakazawa T; Nakamura M; Matsuda R; Nishimura F; Park YS; Motoyama Y; Hironaka Y; Nakagawa I; Yokota H; Yamada S; Tamura K; Takeshima Y; Omoto K; Tanaka Y; Ouji Y; Yoshikawa M; Tsujimura T; Nakase H
    J Neurooncol; 2016 Sep; 129(2):231-41. PubMed ID: 27393349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible site-specific reagent for the general amino acid transport system of Saccharomyces cerevisiae.
    Larimore FS; Roon RJ
    Biochemistry; 1978 Feb; 17(3):431-6. PubMed ID: 339948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
    Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
    J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitro.
    Elo H
    Chemotherapy; 2004 Nov; 50(5):229-33. PubMed ID: 15528888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-liver cancer activity in vitro and in vivo induced by 2-pyridyl 2,3-thiazole derivatives.
    Dos Santos Silva TD; Bomfim LM; da Cruz Rodrigues ACB; Dias RB; Sales CBS; Rocha CAG; Soares MBP; Bezerra DP; de Oliveira Cardoso MV; Leite ACL; Militão GCG
    Toxicol Appl Pharmacol; 2017 Aug; 329():212-223. PubMed ID: 28610992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor.
    Takeda M; Arao T; Yokote H; Komatsu T; Yanagihara K; Sasaki H; Yamada Y; Tamura T; Fukuoka K; Kimura H; Saijo N; Nishio K
    Clin Cancer Res; 2007 May; 13(10):3051-7. PubMed ID: 17505008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.